The Inhibitory Effects of Zinc Oxide Nanoparticles on Clinical Isolates of Malassezia in Dogs
Open Access
- 27 November 2025
- journal article
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (1) , e70646
Abstract
Introduction: Malassezia pachydermatis is frequently detected among the microflora of endothermic vertebrates, acts opportunistically, and contributes to the development of dermatitis and otitis in humans and animals. Treating chronic or recurrent cases of external otitis can pose a challenge, and replacing common antibiotics and antifungal agents with nanoparticles can be crucial in mitigating drug resistance. The present study investigated zinc oxide (ZnO) nanoparticles' antifungal effects on Malassezia pachydermatis clinical isolates and Phospholipase A2 and Aspartyl proteinase gene expression. Materials and methods: Zinc oxide nanoparticles were prepared using the direct precipitation method at a concentration of 2000 ppm. Its antifungal potential was evaluated at concentrations of 1.95 to 2000 ppm by disk diffusion and micro‐dilution methods against ten isolates of Malassezia pachydermatis . The effect of this product on Phospholipase A2 and Aspartyl proteinase gene expression was investigated by Quantitative real‐time PCR method. Results: The results of the disk diffusion test showed that the highest inhibitory diameter was at the highest concentration of ZnO nanoparticles (23.9 mm), and the inhibitory zone was observed in dilutions up to 250 ppm. The minimum inhibitory concentration of ZnO nanoparticles was between 3.90 and 7.81 ppm, and the minimum fungicidal concentration was between 7.81 and 15.62 ppm. There was a significant reduction in Phospholipase A2 and Aspartyl proteinase gene expression in sub‐MIC concentration (1.95–3.90 ppm) ( p < 0.05). Conclusion: The present study provides evidence of the concentration‐dependent antifungal activity of ZnO nanoparticles on Malassezia pachydermatis and suggests that they may be a viable alternative to traditional antifungal agents. Further research is necessary to explore the safety and efficacy of these nanoparticles in vivo.Keywords
This publication has 19 references indexed in Scilit:
- Beneficial and toxicological aspects of zinc oxide nanoparticles in animalsVeterinary Medicine and Science, 2022
- Antifungal Resistance Regarding Malassezia pachydermatis: Where Are We Now?Journal of Fungi, 2020
- Canine otitis externa - Treatment and complications2019
- Malassezia ecology, pathophysiology, and treatmentMedical Mycology, 2018
- Yeast identification by sequencing, biochemical kits, MALDI–TOF MS and rep-PCR DNA fingerprintingMedical Mycology, 2017
- Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocolVeterinary Microbiology, 2012
- Caspofungin Susceptibility Testing of Candida inconspicua : Correlation of Different Methods with the Minimal Fungicidal ConcentrationAntimicrobial Agents and Chemotherapy, 2005
- Immunology of Diseases Associated withMalasseziaSpeciesClinical Microbiology Reviews, 2002
- Fungicidal versus fungistatic activity of terbinafine and itraconazole: An in vitro comparisonJournal of the American Academy of Dermatology, 1998
- Direct staining on vinyl plastic tape, demonstration of the cutaneous flora of the epidermis by the strip methodMedical Mycology, 1962